Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Other 1Classical hematology 1

Conditions

Hematologic Neoplasms 2Pancreatic Neoplasms 1Pain, Postoperative 1Pain, Intractable 1Neoplasms 1Neoplasm Metastasis 1Mucositis 1Malignant Female Reproductive System Neoplasm 1Liver Neoplasms 1Leukemia 1Kidney Neoplasms 1Duodenal Neoplasms 1Digestive System Diseases 1Carcinoma, Hepatocellular 1Bone Marrow Failure Disorders 1Anemia, Aplastic 1Agnosia 1

Interventions

Cyclophosphamide 8Whole-Body Irradiation 7fludarabine phosphate 6Peripheral Blood Stem Cell Transplantation 5Mycophenolic Acid 5fludarabine 4Tacrolimus 4Melphalan 4Busulfan 4Stem Cell Transplantation 2Sirolimus 2nicotinamide-beta-riboside 1methanesulfonic acid 1daratumumab 1X-Rays 1Valganciclovir 1Transplantation 1Therapeutics 1Specimen Handling 1Radiotherapy 1Polymerase Chain Reaction 1Passive Cutaneous Anaphylaxis 1Morphine 1Methotrexate 1Methadone 1Mesna 1Influenza Vaccines 1Hydromorphone 1Honey 1Hematopoietic Stem Cell Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Anemia, Aplastic × Hydromorphone × 1 year × Clear all
NCT06940570 2025-10-23

MATCH

University of Texas Southwestern Medical Center

Phase 3 Suspended
60 enrolled
Classical hematologyOtherOther hematologic neoplasm

Bone Marrow Failure Disorders, Anemia, Aplastic, Leukemia, Neoplasms, Pain, Intractable, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡